Dr. Mohamed Nagy is a clinical pharmacogenomics expert with extensive experience in research, teaching, and clinical practice. He currently serves as the Pharmacy Director at the Children's Cancer Hospital Egypt (CCHE) 57357, where he also founded and heads the Personalized Medication Management Unit. Dr. Nagy's research interests lie in the field of pharmacogenomics, particularly in the application of genetic information to optimize drug therapy in pediatric oncology patients. Dr. Nagy is a recognized leader in the field of pharmacogenomics, serving on the boards of the African Pharmacogenomics Network and he is the chair of the global committee of the Pharmacogenomics Global Research Network. He has also been invited to speak at numerous conferences and workshops worldwide. Dr. Nagy's contributions to the field of pharmacogenomics have been recognized through various awards and grants. In addition to his clinical work, Dr. Nagy is actively involved in teaching and training. He holds adjunct instructor positions at several universities, where he teaches pharmacogenomics, personalized medicine, and nutrigenomics. He is also a preceptor for the ASHP Accredited PGY1 Residency at CCHE and an accredited clinical pharmacy preceptor for the Colorado University Pharm D Program.